Literature DB >> 25541298

Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo.

Antonio Pérez-Martínez1, Jaime Valentín2, Lucía Fernández3, Enrique Hernández-Jiménez2, Eduardo López-Collazo2, Petra Zerbes4, Ellen Schwörer4, Fernando Nuñéz5, Inmaculada Génesis Martín5, Hannah Sallis6, Miguel Ángel Díaz7, Rupert Handgretinger4, Matthias Manuel Pfeiffer4.   

Abstract

BACKGROUND AIMS: Natural killer cell (NK) cytotoxic activity plays a major role in natural immunologic defences against malignancies. NK cells are emerging as a tool for adoptive cancer immunotherapies. Arabinoxylan rice bran (MGN-3/Biobran) has been described as a biological response modifier that can enhance the cytotoxic activity of NK cells. This study evaluated the effect of MGN-3/Biobran on NK cell activation, expansion and cytotoxicity against neuroblastoma cells.
METHODS: NK cells were enriched with magnetic beads and stimulated with MGN-3/Biobran. NK cell activation was evaluated via analysis of their phenotype, and their expansion capability was tracked. The in vitro cytotoxic ability of the activated NK cells was tested against K562, Jurkat, A673, NB1691, A-204, RD and RH-30 cell lines and the in vivo cytotoxic ability against the NB1691 cell line.
RESULTS: MGN-3/Biobran stimulation of NK cells induced a higher expression of the activation-associated receptors CD25 and CD69 than in unstimulated cells (P < 0.05). The expression of NKG2D, DNAM, NCRs and TLRs remained unchanged. Overnight MGN-3/Biobran stimulation increased NK cell cytotoxic activity against all cell lines tested in vitro and decelerated neuroblastoma growth in vivo. The mechanism is not mediated by lipopolysaccharide contamination in MGN-3/Biobran. Furthermore, the addition of MGN-3/Biobran promoted NK cell expansion and decreased T cells in vitro.
CONCLUSIONS: Our data show that MGN-3/Biobran upregulates NK cell activation markers, stimulates NK cell cytotoxic activity against neuroblastoma in vitro and in vivo and selectively augments the expansion of NK cells. These results may be useful for future NK cell therapeutic strategies of the treatment of neuroblastoma.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  arabinoxylan rice bran (MGN-3/Biobran); cytotoxic activity; natural killer (NK) cells; neuroblastoma

Mesh:

Substances:

Year:  2014        PMID: 25541298     DOI: 10.1016/j.jcyt.2014.11.001

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  14 in total

Review 1.  Cellular immunotherapies for cancer.

Authors:  Pedro Berraondo; Sara Labiano; Luna Minute; Iñaki Etxeberria; Marcos Vasquez; Alvaro Sanchez-Arraez; Alvaro Teijeira; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

2.  Arabinoxylan rice bran (Biobran) suppresses the viremia level in patients with chronic HCV infection: A randomized trial.

Authors:  Hosny Salama; Eman Medhat; Magda Shaheen; Abdel-Rahman N Zekri; Tarneem Darwish; Mamdooh Ghoneum
Journal:  Int J Immunopathol Pharmacol       Date:  2016-10-31       Impact factor: 3.219

Review 3.  The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.

Authors:  Soo Liang Ooi; Sok Cheon Pak; Peter S Micalos; Emily Schupfer; Catherine Lockley; Mi Houn Park; Sung-Joo Hwang
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

4.  Chemopreventive Activity of MGN-3/Biobran Against Chemical Induction of Glandular Stomach Carcinogenesis in Rats and Its Apoptotic Effect in Gastric Cancer Cells.

Authors:  Nariman K Badr El-Din; Salma M Abdel Fattah; Deyu Pan; Lucilene Tolentino; Mamdooh Ghoneum
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

Review 5.  Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.

Authors:  Soo Liang Ooi; Debbie McMullen; Terry Golombick; Dipl Nut; Sok Cheon Pak
Journal:  Integr Cancer Ther       Date:  2017-10-17       Impact factor: 3.279

6.  Preparing  for the Decade of Healthy Aging (2020-2030): prevention plus therapy?

Authors:  Domenico Cucinotta
Journal:  Acta Biomed       Date:  2018-06-07

7.  Biobran/MGN-3, an arabinoxylan rice bran, enhances NK cell activity in geriatric subjects: A randomized, double-blind, placebo-controlled clinical trial.

Authors:  Ahmed F Elsaid; Magda Shaheen; Mamdooh Ghoneum
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.751

8.  Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis in vitro via VEGFR2 and its downstream signaling pathways.

Authors:  Xia Zhu; Aya Okubo; Naoki Igari; Kentaro Ninomiya; Yukari Egashira
Journal:  Biosci Microbiota Food Health       Date:  2016-12-27

9.  Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial.

Authors:  Soo Liang Ooi; Sok Cheon Pak; Peter S Micalos; Emily Schupfer; Rob Zielinski; Thomas Jeffries; Garth Harris; Terry Golombick; David McKinnon
Journal:  Contemp Clin Trials Commun       Date:  2020-05-29

Review 10.  Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review.

Authors:  Abdullah Al Mamun Sohag; Md Abdul Hannan; Sadaqur Rahman; Motaher Hossain; Mahmudul Hasan; Md Kawsar Khan; Amena Khatun; Raju Dash; Md Jamal Uddin
Journal:  Drug Dev Res       Date:  2020-07-06       Impact factor: 5.004

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.